AMICUS THERAPEUTICS, INC. — Director's Dealing 2023

Jan 19, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2023-01-18

Reporting Person: Clark David Michael (Chief People Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-18	Common Stock	S	7382	$13.50	Disposed	241067	Direct

Footnotes

F1: The sale of common stock was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.